Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(25%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_1
1
8%
Ph phase_4
3
25%
Ph phase_3
5
42%
Ph phase_2
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
5(50.0%)
Phase 4Post-market surveillance
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(6)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting3
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 21 (10.0%)
Phase 35 (50.0%)
Phase 43 (30.0%)

Trials by Status

enrolling_by_invitation18%
completed542%
recruiting325%
not_yet_recruiting217%
withdrawn18%

Recent Activity

3 active trials
Showing 5 of 12
recruitingphase_4

Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

NCT06846853
enrolling_by_invitation

Gadopiclenol vs Gadoxetate MRI for Liver Lesions

NCT06596616
not_yet_recruitingphase_3

Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

NCT07348640
recruitingphase_4

Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings

NCT07040865
completedphase_2

Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age

NCT05590884
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06846853Phase 4

Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

Recruiting
NCT06596616

Gadopiclenol vs Gadoxetate MRI for Liver Lesions

Enrolling By Invitation
NCT07348640Phase 3

Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

Not Yet Recruiting
NCT07040865Phase 4

Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings

Recruiting
NCT05590884Phase 2

Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age

Completed
NCT03986138Phase 3

Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)

Completed
NCT06226129Phase 4

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Recruiting
NCT03996447Phase 3

Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Completed
NCT06010173Phase 3

Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children

Completed
NCT06127810

MRI Gadopiclenol Enhanced Imaging of CNS Tumors

Withdrawn
NCT06406517Phase 3

Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

Not Yet Recruiting
NCT04906005Phase 1

Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12